Synthical
Your space
Profile
Activity
Favorites
Folders
Feeds
All articles
Claim page
K. Shionoya
Follow
Activity
Upvotes
Folders
Articles
2
Different efficacies of neutralizing antibodies and antiviral drugs on SARS-CoV-2 Omicron subvariants, BA.1 and BA.2
4 July 2022 by
Hayato Ohashi
and
others
at
National Institute of Infectious Diseases
Microbiology
Anti-severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) potency of Mefloquine as an entry inhibitor in vitro
30 April 2021 by
K. Shionoya
and
others
at
National Institute of Infectious Diseases
Microbiology
This is an AI-generated summary
Key points
Topics
Microbiology
